Loading . . .
  • About Us
    • Mission & Vision
    • Strategic Plan
    • Board of Directors
    • Staff
  • Resources
    • Guidelines
    • List of Recommended Devices
    • Professional Certification Program
    • Educational Resources
  • Advocacy
  • Membership
  • News/eINFO
  • Events
    • General Information
    • 2025 Virtual Congress
    • May Measurement Month
    • June Webinar
  • Awards
    • General awards
    • MMM contest winners
  • Contact Us
  • Donate
  • Français

Guidelines

  • 2025 Primary Care Guidelines
    • Routine screening test and Adaptation process
    • Responses to frequent questions
    • COI policy
    • Patient Guidelines
    • Online resources
  • Full 2020-2025 Guidelines
  • Diagnosis and Assessment
    • Accurate Measurement of BP
    • Diagnosis of hypertension and follow-up
    • Routine and optional laboratory tests for the investigation of patients with hypertension
    • Assessment of overall cardiovascular risk in hypertensive patients
    • Assessment of renovascular hypertension
    • Assessment for endocrine hypertension
    • Supplementary Tables
  • Prevention and Treatment
    • Global vascular protection therapy for adults with hypertension without compelling indications for specific agents
    • Health behaviour management
    • Indications for drug therapy for adults with hypertension without compelling indications for specific agents
    • Choice of therapy for adults with hypertension without compelling indications for specific agents
    • Treatment of hypertension in association with diabetes mellitus
    • Treatment of hypertension in association with nondiabetic chronic kidney disease
    • Treatment of hypertension in association with stroke
    • Treatment of hypertension in association with ischemic heart disease
    • Treatment of hypertension in association with heart failure
    • Treatment of hypertension in association with left ventricular hypertrophy
    • Resistant hypertension
    • Treatment of hypertension in association with renovascular disease
    • Treatment of secondary hypertension due to endocrine causes
    • Adherence strategies for patients
    • Supplementary Tables
  • About Guidelines
  • Credits
  • References

The 2025 Hypertension Canada Guidelines consists of 2 parts: A Primary Care Guideline and a Comprehensive Guideline for the more specialized topics (1) .

The Primary Care Guideline is designed to be a practical, easily applied tool which represents a balance of best available evidence and pragmatism (2). The committee consisted of volunteers representing primary care (the majority of members), patient partners, a guidelines methodologist and hypertension specialists. We followed Grading of Recommendations Assessment, Development and Evaluation (GRADE) and ADAPTE frameworks were employed in accordance with Appraisal of Guidelines for Research and Evaluation (AGREE II) quality and reporting standards to develop the recommendations. We used the HEARTS framework to create pragmatic algorithms for diagnosis and treatment. We utilized the Guidelines International Network principles to manage competing interests.

The Primary Care Guidelines process also includes Patient/Public Guidelines, published here.

The Comprehensive Guidelines are starting with a topic prioritization exercise, whereby we will solicit the hypertension community and stakeholders to suggest topics. These topics will be evaluated using a comprehensive evidence synthesis. The Comprehensive Guidelines will be “living” guidelines, for which we will update continuously. The first of the topics should be ready for late 2025.

  • About Us
    • Mission & Vision
    • Strategic Plan
    • Position Statements
    • Board of Directors
    • Staff
  • Resources
    • Guidelines
    • List of Recommended Devices
    • Professional Certification Program
    • Educational Resources
  • About Us
  • Resources
  • Advocacy
  • Membership
  • News/eINFO
  • Events
  • Awards
  • Contact Us
  • Donate
  • Français

Privacy Policy | Terms of Use

© 2025 Hypertension Canada. All rights reserved. Unauthorized
use prohibited. Hypertension Canada does not provide medical
advice, diagnosis or treatment.